Free Trial
NASDAQ:MBIO

Mustang Bio (MBIO) Stock Price, News & Analysis

Mustang Bio logo
$1.75 +0.19 (+12.18%)
Closing price 10/7/2025 04:00 PM Eastern
Extended Trading
$1.74 -0.01 (-0.86%)
As of 10/7/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Mustang Bio Stock (NASDAQ:MBIO)

Advanced

Key Stats

Today's Range
$1.58
$1.75
50-Day Range
$1.36
$1.87
52-Week Range
$0.89
$21.95
Volume
377,547 shs
Average Volume
103,299 shs
Market Capitalization
$12.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Mustang Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
19th Percentile Overall Score

MBIO MarketRank™: 

Mustang Bio scored higher than 19% of companies evaluated by MarketBeat, and ranked 865th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Mustang Bio are expected to grow in the coming year, from ($35.00) to ($19.50) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Mustang Bio is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Mustang Bio is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Mustang Bio's valuation and earnings.
  • Percentage of Shares Shorted

    1.34% of the float of Mustang Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Mustang Bio has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Mustang Bio has recently decreased by 43.47%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Mustang Bio does not currently pay a dividend.

  • Dividend Growth

    Mustang Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.34% of the float of Mustang Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Mustang Bio has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Mustang Bio has recently decreased by 43.47%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Mustang Bio has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.
  • MarketBeat Follows

    Only 1 people have added Mustang Bio to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Mustang Bio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.21% of the stock of Mustang Bio is held by insiders.

  • Percentage Held by Institutions

    Only 9.95% of the stock of Mustang Bio is held by institutions.

  • Read more about Mustang Bio's insider trading history.
Receive MBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mustang Bio and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MBIO Stock News Headlines

Mustang Bio Inc.
This is the “End of Tesla” as we know it…
Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla call alone could have made readers 21 TIMES THEIR MONEY, if they listened to his recommendation. Don't miss his next big prediction.tc pixel
Mustang Bio Inc News (MBIO) - Investing.com
Dow Dips 1%; Mustang Bio Shares Spike Higher
See More Headlines

MBIO Stock Analysis - Frequently Asked Questions

Mustang Bio's stock was trading at $8.85 at the beginning of 2025. Since then, MBIO stock has decreased by 80.2% and is now trading at $1.75.

Mustang Bio, Inc. (NASDAQ:MBIO) released its quarterly earnings results on Friday, August, 8th. The company reported ($0.19) earnings per share (EPS) for the quarter.

Mustang Bio's stock reverse split on the morning of Thursday, January 16th 2025.The 1-50 reverse split was announced on Tuesday, January 14th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, January 15th 2025. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of MBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mustang Bio investors own include BMO Capital Markets (), Stifel Nicolaus (), Wunderlich (), Standpoint Research (), Duncan Williams (), Soleil Securities () and Sterne Agee CRT ().

Company Calendar

Last Earnings
8/08/2025
Today
10/07/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MBIO
CIK
1680048
Fax
N/A
Employees
100
Year Founded
2015

Profitability

EPS (Trailing Twelve Months)
($78.00)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.75 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-29.49%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.30
Quick Ratio
1.30

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.11) per share
Price / Book
-0.83

Miscellaneous

Outstanding Shares
7,240,000
Free Float
7,225,000
Market Cap
$12.67 million
Optionable
Not Optionable
Beta
2.29

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:MBIO) was last updated on 10/8/2025 by MarketBeat.com Staff
From Our Partners